SurModics Inc (NASDAQ:SRDX) — Market Cap & Net Worth
Market Cap & Net Worth: SurModics Inc (SRDX)
SurModics Inc (NASDAQ:SRDX) has a market capitalization of $614.51 Million ($614.51 Million) as of May 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #11487 globally and #2763 in its home market, demonstrating a 57.18% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SurModics Inc's stock price $42.98 by its total outstanding shares 14297623 (14.30 Million). Analyse SurModics Inc (SRDX) cash conversion ratio to see how efficiently the company converts income to cash.
SurModics Inc Market Cap History: 2015 to 2025
SurModics Inc's market capitalization history from 2015 to 2025. Data shows growth from $289.81 Million to $614.51 Million (6.98% CAGR).
Index Memberships
SurModics Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.41 Trillion | 0.03% | #300 of 976 |
|
NASDAQ Composite
IXIC
|
$38.77 Trillion | 0.00% | #1109 of 3165 |
Weight: SurModics Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
SurModics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SurModics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
4.49x
SurModics Inc's market cap is 4.49 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $289.81 Million | $61.90 Million | $13.45 Million | 4.68x | 21.55x |
| 2016 | $363.16 Million | $71.37 Million | $9.98 Million | 5.09x | 36.37x |
| 2017 | $400.33 Million | $73.11 Million | $3.93 Million | 5.48x | 101.97x |
| 2018 | $675.71 Million | $81.34 Million | -$4.46 Million | 8.31x | N/A |
| 2019 | $592.35 Million | $100.08 Million | $7.59 Million | 5.92x | 78.02x |
| 2020 | $622.23 Million | $94.86 Million | $1.12 Million | 6.56x | 554.08x |
| 2021 | $688.43 Million | $105.14 Million | $4.24 Million | 6.55x | 162.48x |
| 2022 | $487.83 Million | $99.95 Million | -$27.27 Million | 4.88x | N/A |
| 2023 | $519.72 Million | $132.58 Million | -$1.54 Million | 3.92x | N/A |
| 2024 | $566.19 Million | $126.08 Million | -$11.54 Million | 4.49x | N/A |
Competitor Companies of SRDX by Market Capitalization
Companies near SurModics Inc in the global market cap rankings as of May 4, 2026.
Key companies related to SurModics Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
SurModics Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, SurModics Inc's market cap moved from $289.81 Million to $ 614.51 Million, with a yearly change of 6.98%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $614.51 Million | +8.54% |
| 2024 | $566.19 Million | +8.94% |
| 2023 | $519.72 Million | +6.54% |
| 2022 | $487.83 Million | -29.14% |
| 2021 | $688.43 Million | +10.64% |
| 2020 | $622.23 Million | +5.04% |
| 2019 | $592.35 Million | -12.34% |
| 2018 | $675.71 Million | +68.79% |
| 2017 | $400.33 Million | +10.24% |
| 2016 | $363.16 Million | +25.31% |
| 2015 | $289.81 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of SurModics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $614.51 Million USD |
| MoneyControl | $614.51 Million USD |
| MarketWatch | $614.51 Million USD |
| marketcap.company | $614.51 Million USD |
| Reuters | $614.51 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About SurModics Inc
Surmodics, Inc., together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision o… Read more